Key facts
- Brinter’s last known valuation is $14.0M (Dec 2024).
- It has raised $3.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Plug and Play Tech Center, Techstars, Innovestor, Athensmed, Winston Starts.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Brinter
- ·The full record, as it builds
Funding rounds
No funding rounds for Brinter are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brinter
Developer of a medical-grade multi-material three-dimensional bioprinting platform intended to create regenerative implants that support tissue repair. The company offers bio-inductive fully resorbable implants and high-volume manufacturing capabilities, enabling healthcare providers in orthopedics and aesthetics to improve healing outcomes.
- Sector
- Healthcare
- HQ
- Winston-Salem, NC, United States
- Founded
- 2020
- Employees
- 12
- Website
- brinteram.com/
- Ownership
- Privately Held (backing)
Brinter doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brinter shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brinter in its N-PORT filings yet. We sweep new filings monthly.